CXCR4-directed PET/CT in patients with newly diagnosed neuroendocrine carcinomas
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Diagnostics, 11, 4, S. 605-
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2021
- Ereignis
-
Veröffentlichung
- (wer)
-
MDPI
- (wann)
-
2021
- Urheber
-
Weich, Alexander
Wolf, Herta
Buck, Andreas K.
Hartrampf, Philipp E.
Serfling, Sebastian E.
Scheurlen, Michael
Wester, Hans-Jürgen
Meining, Alexander
Kircher, Stefan
Higuchi, Takahiro
Pomper, Martin G.
Rowe, Steven P.
Lapa, Constantin Frederik Victor
Kircher, Malte
- DOI
-
10.3390/diagnostics11040605
- URN
-
urn:nbn:de:bvb:384-opus4-853748
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:49 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Weich, Alexander
- Wolf, Herta
- Buck, Andreas K.
- Hartrampf, Philipp E.
- Serfling, Sebastian E.
- Scheurlen, Michael
- Wester, Hans-Jürgen
- Meining, Alexander
- Kircher, Stefan
- Higuchi, Takahiro
- Pomper, Martin G.
- Rowe, Steven P.
- Lapa, Constantin Frederik Victor
- Kircher, Malte
- Universität Augsburg
- MDPI
Entstanden
- 2021
Ähnliche Objekte (12)
![[68Ga]-Pentixafor PET/CT for CXCR4-mediated imaging of vestibular schwannomas](/assets/placeholder/searchResultMediaUnknown.png)
[68Ga]-Pentixafor PET/CT for CXCR4-mediated imaging of vestibular schwannomas
68Ga-Pentixafor PET/CT for CXCR4-mediated imaging of vestibular schwannomas
Somatostatin receptor PET/CT in the management of patients with neuroendocrine tumors
Interobserver concordance rates in cancer patients imaged with CXCR4-directed PET/CT [Abstract]
Improved primary staging of marginal-zone lymphoma by addition of CXCR4-directed PET/CT
68Ga-pentixafor PET/CT for detection of chemokine receptor CXCR4 expression in myeloproliferative neoplasms
NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas
Wnt/β-catenin signaling regulates CXCR4 expression and [\(^68}\)Ga] Pentixafor internalization in neuroendocrine tumor cells
CXCR4-directed PET/CT in 100 patients with marginal zone lymphoma – superior diagnostic performance, predictive potential and eligibility for CXCR4-directed endoradiotherapy [Abstract]
Neuroendocrine disrupters
PET/CT radiomics and machine learning for non-invasive molecular and prognostic characterization of oropharyngeal squamous cell carcinomas
Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features
[68Ga]-Pentixafor PET/CT for CXCR4-mediated imaging of vestibular schwannomas
68Ga-Pentixafor PET/CT for CXCR4-mediated imaging of vestibular schwannomas
Somatostatin receptor PET/CT in the management of patients with neuroendocrine tumors
Interobserver concordance rates in cancer patients imaged with CXCR4-directed PET/CT [Abstract]
Improved primary staging of marginal-zone lymphoma by addition of CXCR4-directed PET/CT
68Ga-pentixafor PET/CT for detection of chemokine receptor CXCR4 expression in myeloproliferative neoplasms
NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas
Wnt/β-catenin signaling regulates CXCR4 expression and [\(^68}\)Ga] Pentixafor internalization in neuroendocrine tumor cells
CXCR4-directed PET/CT in 100 patients with marginal zone lymphoma – superior diagnostic performance, predictive potential and eligibility for CXCR4-directed endoradiotherapy [Abstract]
Neuroendocrine disrupters
PET/CT radiomics and machine learning for non-invasive molecular and prognostic characterization of oropharyngeal squamous cell carcinomas
Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features
[68Ga]-Pentixafor PET/CT for CXCR4-mediated imaging of vestibular schwannomas
68Ga-Pentixafor PET/CT for CXCR4-mediated imaging of vestibular schwannomas
Somatostatin receptor PET/CT in the management of patients with neuroendocrine tumors
Interobserver concordance rates in cancer patients imaged with CXCR4-directed PET/CT [Abstract]
Improved primary staging of marginal-zone lymphoma by addition of CXCR4-directed PET/CT
68Ga-pentixafor PET/CT for detection of chemokine receptor CXCR4 expression in myeloproliferative neoplasms
NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas
Wnt/β-catenin signaling regulates CXCR4 expression and [\(^68}\)Ga] Pentixafor internalization in neuroendocrine tumor cells
CXCR4-directed PET/CT in 100 patients with marginal zone lymphoma – superior diagnostic performance, predictive potential and eligibility for CXCR4-directed endoradiotherapy [Abstract]
Neuroendocrine disrupters
PET/CT radiomics and machine learning for non-invasive molecular and prognostic characterization of oropharyngeal squamous cell carcinomas